Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

BACKGROUND: Pre-treatment factors that increase smokers’ risk of experiencing neuropsychiatric adverse events (NPSAEs) when quitting smoking are unknown. OBJECTIVE: To identify baseline smoker characteristics beyond the history of mental illness that predict which participants were more likely to ex...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Gen Intern Med
Hoofdauteurs: Anthenelli, Robert M., Gaffney, Michael, Benowitz, Neal L., West, Robert, McRae, Thomas, Russ, Cristina, Lawrence, David, St. Aubin, Lisa, Krishen, Alok, Evins, A. Eden
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544691/
https://ncbi.nlm.nih.gov/pubmed/30847828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-019-04858-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items